These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1309043)

  • 1. Regulation of the acute release of tissue-type plasminogen activator from the endothelium by coagulation activation products.
    Emeis JJ
    Ann N Y Acad Sci; 1992 Dec; 667():249-58. PubMed ID: 1309043
    [No Abstract]   [Full Text] [Related]  

  • 2. Release of tissue plasminogen activator during coronary angioplasty.
    Weyne A; de Buyzere M; Clement D; Baele G; Leroux-Roels G
    Lancet; 1990 Mar; 335(8690):658. PubMed ID: 1969029
    [No Abstract]   [Full Text] [Related]  

  • 3. Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo.
    Lang NN; Gudmundsdóttir IJ; Boon NA; Ludlam CA; Fox KA; Newby DE
    J Am Coll Cardiol; 2008 Jul; 52(1):33-9. PubMed ID: 18582632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological stimulation of t-PA release.
    Klöcking HP; Markwardt F
    Pharmazie; 1994 Apr; 49(4):227-30. PubMed ID: 7910971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme secretion by human endothelial cells infected with Rickettsia conorii.
    Raoult D; Drancourt AM; Ardissone JP
    Acta Virol; 1987 Aug; 31(4):352-6. PubMed ID: 2892385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the fibrinolytic potential of cultured human umbilical vein endothelial cells: astragaloside IV downregulates plasminogen activator inhibitor-1 and upregulates tissue-type plasminogen activator expression.
    Zhang WJ; Wojta J; Binder BR
    J Vasc Res; 1997; 34(4):273-80. PubMed ID: 9256087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemostatic function and coronary artery disease.
    Hamsten A
    N Engl J Med; 1995 Mar; 332(10):677-8. PubMed ID: 7845435
    [No Abstract]   [Full Text] [Related]  

  • 8. Extracellular matrix produced by cultured corneal and aortic endothelial cells contains active tissue-type and urokinase-type plasminogen activators.
    Korner G; Bjornsson TD; Vlodavsky I
    J Cell Physiol; 1993 Mar; 154(3):456-65. PubMed ID: 8436596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term effects of transdermal nicotine on acute tissue plasminogen activator release in vivo in man.
    Pellegrini MP; Newby DE; Maxwell S; Webb DJ
    Cardiovasc Res; 2001 Nov; 52(2):321-7. PubMed ID: 11684081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes of blood coagulative and fibrinolytic systems and functions of pulmonary vascular endothelium in patients with pulmonary thromboembolism].
    Pang BS; Wang C; Zhai ZG; Yang YH; Mao YL; Huang XX; Zhu J
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Oct; 28(10):714-6. PubMed ID: 16255959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular structures and functions of coagulation and fibrinolytic factors].
    Suzuki K; Deyashiki Y
    Rinsho Byori; 1987 Apr; Spec No 70():13-42. PubMed ID: 3112445
    [No Abstract]   [Full Text] [Related]  

  • 12. Anesthesia and surgery influences regional net release and uptake rates of tissue-type plasminogen activator. An experimental study in the intact pig.
    Seeman-Lodding H; Biber B; Häggmark S; Jern C; Jern S; Johansson G; Winsö O
    Acta Anaesthesiol Scand Suppl; 1997; 110():151-3. PubMed ID: 9248570
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter by Brown and Pretorius regarding article, "effect of sulfaphenazole on tissue plasminogen activator release in normotensive subjects and hypertensive patients".
    Brown NJ; Pretorius M
    Circulation; 2009 Nov; 120(19):e159; author reply e160. PubMed ID: 19901200
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulation of local availability of active tissue-type plasminogen activator in vivo in man.
    Hrafnkelsdottir T; Gudnason T; Wall U; Jern C; Jern S
    J Thromb Haemost; 2004 Nov; 2(11):1960-8. PubMed ID: 15550028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Levels of tissue-type plasminogen activator and plasminogen activator inhibitor 1 in disseminated intravascular coagulation syndrome].
    Fukao H; Yamamoto K; Matsuo O
    Rinsho Byori; 1991 Jul; 39(7):720-6. PubMed ID: 1920864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-type plasminogen activator release: new frontiers in endothelial function.
    Muldowney JA; Vaughan DE
    J Am Coll Cardiol; 2002 Sep; 40(5):967-9. PubMed ID: 12225724
    [No Abstract]   [Full Text] [Related]  

  • 17. Stimulated tissue plasminogen activator release as a marker of endothelial function in humans.
    Oliver JJ; Webb DJ; Newby DE
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2470-9. PubMed ID: 16210566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinolysis during cardiac surgery. Release of tissue plasminogen activator in arterial and coronary sinus blood.
    Valen G; Eriksson E; Risberg B; Vaage J
    Eur J Cardiothorac Surg; 1994; 8(6):324-30. PubMed ID: 8086178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid selectively increases vascular endothelial tissue-type plasminogen activator production and reduces thrombus formation in the mouse.
    Larsson P; Alwis I; Niego B; Sashindranath M; Fogelstrand P; Wu MC; Glise L; Magnusson M; Daglas M; Bergh N; Jackson SP; Medcalf RL; Jern S
    J Thromb Haemost; 2016 Dec; 14(12):2496-2508. PubMed ID: 27706906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro diagnosis of fibrinolysis: present status and desired improvements.
    Kluft C
    Ann N Y Acad Sci; 1992 Dec; 667():291-304. PubMed ID: 1309050
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.